Prenatal Cell-Free DNA Screening Evaluated for Routine 22q11.2 Deletion Syndrome Detection
A comprehensive clinical perspective evaluates the evidence supporting routine prenatal cell-free DNA screening for 22q11.2 deletion syndrome across obstetrical populations.


